CD86+1057G/A polymorphism and susceptibility to osteosarcoma

DNA and Cell Biology

Volumn 30, Issue 11, 2011, Pages 925-929

  Wang, Wen ^a   Song, Haihan ^b   Liu, Jie ^c   Song, Bao ^c   Cao, Xuecheng ^a  

^a JINAN MILITARY GENERAL HOSPITAL   (China)

^b UNIVERSITY OF TORONTO   (Canada)

^c SHANDONG CANCER HOSPITAL AND INSTITUTE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CD86 ANTIGEN;

ADOLESCENT; ADULT; AGED; ALLELE; ARTICLE; CHILD; CHINESE; CONTROLLED STUDY; DISEASE PREDISPOSITION; FEMALE; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; OSTEOSARCOMA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SCHOOL CHILD;

ADOLESCENT; ADULT; AGED; ANTIGENS, CD86; BONE NEOPLASMS; CASE-CONTROL STUDIES; CHILD; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MIDDLE AGED; OSTEOSARCOMA; POLYMORPHISM, SINGLE NUCLEOTIDE; YOUNG ADULT;

EID: 80655128313     PISSN: 10445498     EISSN: 15577430     Source Type: Journal    
DOI: 10.1089/dna.2011.1211     Document Type: Article

References (28)

1. Allison, J.P., Hurwitz, A.A., and Leach, D.R. (1995). Manipulation of costimulatory signals to enhance antitumor T-cell responses. Curr Opin Immunol 7, 682-686.
2. Contardi, E., Palmisano, G.L., Tazzari, P.L., Martelli, A.M., Fala, F., Fabbi, M., Kato, T., Lucarelli, E., Donati, D., Polito, L., Bolognesi, A., Ricci, F., Salvi, S., Gargaglione, V., Mantero, S., Alberghini, M., Ferrara, G.B., and Pistillo, M.P. (2005). CTLA-4 is constitutively expressed on tumor cells and can trigger ap-optosis upon ligand interaction. Int J Cancer 117, 538-550. (Pubitemid 41504541)
3. Corydon, T.J., Haagerup, A., Jensen, T.G., Binderup, H.G., Pe-tersen, M.S., Kaltoft, K., Vestbo, J., Kruse, T.A., and Borglum, A.D. (2007). A functional CD86 polymorphism associated with asthma and related allergic disorders. J Med Genet 44, 509-515. (Pubitemid 47325737)
4. Delneste, Y., Bosotti, R., Magistrelli, G., Bonnefoy, J.Y., and Gauchat, J.F. (2000). Detection of a polymorphism in exon 8 of the human CD86 gene. Immunogenetics 51, 762-763. (Pubitemid 30447215)
5. Dorfman, H.D., and Czerniak, B. (1995). Bone Cancers. Cancer 75, 203-210.
6. Ergen, A., Kilicoglu, O., Ozger, H., Agachan, B., and Isbir, T. (2010). Paraoxonase 1 192 and 55 polymorphisms in osteosarcoma. Mol Biol Rep [Epub ahead of print]; DOI: 10.1007/s11033-010-0538-8.
7. Greenwald, R.J., Freeman, G.J., and Sharpe, A.H. (2005). The B7 family revisited. Annu Rev Immunol 23, 515-548. (Pubitemid 40563179)
8. Handa, T., Nagai, S., Ito, I., Tabuena, R., Shigematsu, M., Ha-mada, K., Kitaichi, M., Izumi, T., Aoyama, T., Toguchida, J., and Mishima, M. (2005). Polymorphisms of B7 (CD80 and CD86) genes do not affect disease susceptibility to sarcoidosis. Respiration 72, 243-248. (Pubitemid 40981082)
9. Hodge, J.W., Abrams, S., Schlom, J., and Kantor, J.A. (1994). Induction of antitumor immunity by recombinant vaccinia viruses expressing B7-1 or B7-2 costimulatory molecules. Cancer Res 54, 5552-5555. (Pubitemid 24346245)
10. Hu, Y.S., Pan, Y., Li, W.H., Zhang, Y., Li, J., and Ma, B.A. (2010). Association between TGFBR1*6A and osteosarcoma: a Chinese case-control study. BMC Cancer 10, 169.
11. Jellis, C.L., Wang, S.S., Rennert, P., Borriello, F., Sharpe, A.H., Green, N.R., and Gray, G.S. (1995). Genomic organization of the gene coding for the costimulatory human B-lymphocyte antigen B7-2 (CD86). Immunogenetics 42, 85-89.
12. Kronfeld, K., Abken, H., and Seliger, B. (2005). B7-1 and B7-2 act differentially in the induction of a T cell response: their impact for a HLA-matched and HLA-mismatched anti-tumor immu-notherapy. Int J Cancer 117, 794-799. (Pubitemid 41598831)
13. Krummel, M.F., and Allison, J.P. (1995). CD28 and CTLA-4 have opposing effects on the response of T cells to stimulation. J Exp Med 182, 459-465.
14. Ligers, A., Teleshova, N., Masterman, T., Huang, W.X., and Hil-lert, J. (2001). CTLA-4 gene expression is influenced by promoter and exon 1 polymorphisms. Genes Immun 2,145-152. (Pubitemid 33674879)
15. Liu, Y., Liang, W.B., Gao, L.B., Pan, X.M., Chen, T.Y., Wang, Y.Y., Xue, H., Zhang, L.S., and Zhang, L. (2010). CTLA4 and CD86 gene polymorphisms and susceptibility to chronic obstructive pulmonary disease. Hum Immunol 71, 1141-1146.
16. Loser, K., Scherer, A., Krummen, M.B.W., Varga, G., Higuchi, T., Schwarz, T., Sharpe, A.H., Grabbe, S., Bluestone, J.A., and Beissert, S. (2005). An important role of CD80/CD86-CTLA-4 signaling during photocarcinogenesis in mice. J Immunol 174, 5298-5305. (Pubitemid 40593168)
17. Marin, L.A., Moya-Quiles, M.R., Miras, M., Muro, M., Minguela, A., Bermejo, J., Ramirez, P., Garcia-Alonso, A.M., Parrilla, P., and Alvarez-Lopez, M.R. (2005). Evaluation of CD86 gene polymorphism at?1057 position in liver transplant recipients. Transpl Immunol 15, 69-74. (Pubitemid 41434010)
18. Matsushita, M., Tsuchiya, N., Oka, T., Yamane, A., and Toku-naga, K. (2000). New polymorphisms of human CD80 and CD86: lack of association with rheumatoid arthritis and systemic lupus erythematosus. Genes Immun 1, 428-434.
19. Nunes, J.A., Truneh, A., Olive, D., and Cantrell, D.A. (1996). Signal transduction by CD28 costimulatory receptor on T cells. B7-1 and B7-2 regulation of tyrosine kinase adaptor molecules. J Biol Chem 271, 1591-1598.
20. Pan, X.M., Gao, L.B., Liang, W.B., Liu, Y., Zhu, Y., Tang, M., Li, Y.B., and Zhang, L. (2010). CD86 +1057 G/A polymorphism and the risk of colorectal cancer. DNA Cell Biol 29, 381-386.
21. Pizzoferrato, E. (2004). B7-2 expression above a threshold elicits anti-tumor immunity as effective as interleukin-12 and prolongs survival in murine B-cell lymphoma. Int J Cancer 110, 61-69. (Pubitemid 38507204)
22. Roitt, I., Brostoff, J., and Male, D. (2001). Immunology, 6th edition (Mosby, London).
23. Salomon, B., and Bluestone, J.A. (2001). Complexities of CD28/B7: CTLA-4 costimulatory pathways in autoimmunity and transplantation. Annu Rev Immunol 19, 225-252. (Pubitemid 32368035)
24. Seliger, B., Marincola, F.M., Ferrone, S., and Abken, H. (2008). The complex role of B7 molecules in tumor immunology. Trends Mol Med 14, 550-559.
25. Slavik, J.M., Hutchcroft, J.E., and Bierer, B.E. (1999). CD80 and CD86 are not equivalent in their ability to induce the tyrosine phosphorylation of CD28. J Biol Chem 274, 3116-3124. (Pubitemid 29075399)
26. Stremmel, C., Greenfield, E.A., Howard, E., Freeman, G.J., and Kuchroo, V.K. (1999). B7-2 expressed on EL4 lymphoma CD86+1057G/A POLYMORPHISM AND CANCER 385 suppresses antitumor immunity by an interleukin 4-dependent mechanism. J Exp Med 189, 919-930. (Pubitemid 29149348)
27. Ueda, Y., Levine, B.L., Huang, M.L., Freeman, G.J., Nadler, L.M., June, C.H., and Ward, S.G. (1995). Both CD28 ligands CD80 (B7-1) and CD86 (B7-2) activate phosphatidylinositol 3-kinase, and wortmannin reveals heterogeneity in the regulation of T cell IL-2 secretion. Int Immunol 7, 957-966.
28. Waterhouse, P., Penninger, J.M., Timms, E., Wakeham, A., Shahinian, A., Lee, K.P., Thompson, C.B., Griesser, H., and Mak, T.W. (1995). Lymphoproliferative disorders with early lethality in mice deficient in Ctla-4. Science 270, 985-988.